Biotech: Pressemitteilungen - Kategorie - Seite 126

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Ceapro Announces Signing of Growing Forward 2 Agreement

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 08/13/13 -- Ceapro Inc. (TSX VENTURE: CZO) is pleased to announce that it has signed an Agri-Processing Automation and Efficiency Grant Agreement with Alberta A ...

The Medicines Company Announces Proposed Public Offering of Common Stock

PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwired) -- 08/12/13 -- The Medicines Company (NASDAQ: MDCO) today announced that it has commenced an underwritten public offering of up to 5,500,000 shares of its common stock ...

Paladin Announces Passing of Founding Chairman, Ted Wise

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/12/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Ted S. Wise, Chairman Emeritus of Paladin ...

ProMetic to Report Its Second Quarter 2013 Highlights and Financial Results and Hold Conference Call / Webcast

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 08/12/13 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") today announced that it will report its finan ...

ImmuCell Announces Increase in Product Sales and Continued Profitability

PORTLAND, ME: PORTLAND, ME -- (Marketwired) -- 08/12/13 -- (NASDAQ: ICCC) today announced the results of its operations for the three-month and six-month periods ended June 30, 2013.During the three-month period e ...

Cellceutix Clinical Study on Its Anti-Psoriasis Drug Prurisol(TM) to Commence

BEVERLY, MA: Company Beginning Process to Move to National Securities Exchange ...

Helix BioPharma Corp. Announces Extension of 2009 Warrant Expiry Date

AURORA, ON: AURORA, ON -- (Marketwired) -- 08/09/13 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today ...

Paladin Labs to Present at the Canaccord Genuity Annual Growth Conference

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/09/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Mr. Mark Beaudet, interim President & CEO ...

Adamis Pharmaceuticals Announces Investor Update Conference Call

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 08/09/13 -- Adamis Pharmaceuticals Corp. (OTCQB: ADMP) ("the Company"), a biopharmaceutical company engaged in the development and commercialization of spe ...

Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/09/13 -- Thallion Pharmaceuticals Inc. ("Thallion") (TSX VENTURE: TLN) and BELLUS Health Inc. (TSX: BLU) ("BELLUS Health") announced today ...

Stem Cell Therapeutics Acquires an Exclusive Option to License Prostate Cancer Stem Cell Assets

TORONTO, ONTARIO: Collaboration with Internationally Renowned Prostate Cancer Research Group ...

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2013 Financial Results

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/08/13 -- . (OTCBB: TTNP) today announced that its management will host a conference call at 10:00am PT / 1:00pm ET on Thursday, August 15, 2013 and prov ...

Mincom Capital Inc. Announces Appointment of New Director

OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 08/08/13 -- Mincom Capital Inc. ("Mincom" or "the Company"), a Capital Pool Company ("CPC") trading on the TSX Venture Exchange (&qu ...

Medivation Reports Second Quarter Financial Results and Provides Corporate Update

SAN FRANCISCO, CA: $82.4 Million in Second Quarter U.S. Net Sales; Conference Call Today at 4:30 p.m. Eastern Time ...

Corcept Therapeutics Announces Second Quarter 2013 Financial Results and Corporate Update

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 08/08/13 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the ...

Sarepta Therapeutics Announces Publication of Eteplirsen Clinical Study Results in the Annals of Neurology

CAMBRIDGE, MA: Results Show a Significant Increase in Dystrophin Production and a Stabilization of Walking Ability in Duchenne Muscular Dystrophy Patients ...

Sarepta Therapeutics Announces Second Quarter 2013 Financial Results and Recent Corporate Developments

CAMBRIDGE, MA: Submission of New Drug Application for Eteplirsen Planned for First Half of 2014; Preparations for Confirmatory Eteplirsen Study and Manufacturing Scale Up Remain on Track; Well Capitalized With $164. ...

Miraculins Retains Network IR to Provide Investor Relations

WINNIPEG, MANITOBA: Vancouver Firm to Enhance Market Communications of Miraculins Advances Including its Acquisition of the SCOUT DS(R) Non-Invasive Diabetes Testing Technology ...


Seite 126 von 255:  « ..  125 126 127  128  129  130  131  132  133  134  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z